ABOUT THE PEPTIDE SYNTHESIS FACILITY

The MPRC Peptide Synthesis Facility, formerly known as The Protein Core, was established as a shared research resource on the Mayo Rochester campus in 1984. Daniel McCormick, Ph.D. is the facility's founder and current director. The facility, along with the Mayo Clinic Cancer Center and the General Clinical Research Center are part of the Mayo genomic and proteomic effort. The facility is housed in Guggenheim 1633 and comprises part of the Mayo Proteomics Research Center (MPRC). The facility provides services in peptide synthesis to Mayo investigators and also conducts research and development of new methods in the field of solid phase peptide synthesis.

The nine full-time professional staff of the facility possess a broad knowledge and expertise in the area of differential and expression proteoimics, protein identification by mass spectrometry and tandem mass spectrometry (MS/MS), chemical protein sequencing, protein purification, polyacrylamide gel electrophoresis (1-D and 2-D), peptide synthesis, protein antigenic analysis, and molecular modeling by computational methods. Links to the list of services offered by the facility and fees for each service are available at the bottom of this web page.

Investigators interested in using specific services offered by the EPPC facility are encouraged to contact the facility's director, Dr. McCormick (507-284-4992 or mccormick.daniel@mayo.edu), or any of the facility's personnel (507-284-2457). For inquiries regarding peptide synthesis, investigators should contact Jane Peterson (507-284-9434) or Patricia Caffes (507-286-1997). E-mail inquiries regarding services may also be directed to personnel of the MPRC using the e-mail addresses, which are listed on the "Personnel" page of this website.

Note: Mayo investigators viewing this webpage from the Mayo Foundation's external website (http://www.mayo.edu) are encouraged to use the internal website for full access to information concerning the Peptide Synthesis Facility and the MPRC.

Please Note: As of January 2004 the C-terminal sequencing service is no longer being offered.